Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
This is a brief. The reporting belongs to CNBC — read the complete story, with full context and credits, at the source.
Read the full story at CNBC ↗cnbc.com
More from the Business desk
Just in
My husband is happily retired at 64 and thinks I should keep working. Is he being fair?
Just in

Robert Pattinson Named as the Next James Bond
Just in
Parents told us what it’s like to help their kids battle sports-gambling addiction: ‘There’s no handbook’
Just in

American Roosters Fight in the Philippines Despite U.S. Crackdown
Just in
